Loading
Latest filing published 28 Oct 2013 for OPTIMER PHARMACEUTICALS INC, €23k.
No signal scores available.
This profile gathers the share dealings of Meredith Schaum in Optimer Pharmaceuticals Inc. Between 15 May 2013 and 24 October 2013, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 28 October 2013 with a transaction (€23k) in Optimer Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations